Exact Mass: 610.3115

Exact Mass Matches: 610.3115

Found 15 metabolites which its exact mass value is equals to given mass value 610.3115, within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error 0.0002 dalton.

BQ-123

Cyclo[D-trp-D-asp-L-pro-D-val-L-leu]

C31H42N6O7 (610.3115)


D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D065128 - Endothelin Receptor Antagonists BQ-123 is a potent and selective endothelin A (ETA) receptor antagonist with an IC50 of 7.3 nM and a Ki of 25 nM. BQ-123 inhibits endothelin-1-mediated proliferation of human pulmonary artery smooth muscle cells and lowers blood pressure in different rat models of hypertension[1][2][3].

   

Cyclo(D-trp-D-asp-pro-D-val-leu)

2-{1,4,7,10-tetrahydroxy-9-[(1H-indol-3-yl)methyl]-6-(2-methylpropyl)-13-oxo-3-(propan-2-yl)-3H,6H,9H,12H,13H,15H,16H,17H,17ah-pyrrolo[1,2-a]1,4,7,10,13-pentaazacyclopentadecan-12-yl}acetate

C31H42N6O7 (610.3115)


   

OS-PG

1-(9Z-octadecenoyl)-2-succinyl-sn-glycero-3-phospho-(1-sn-glycerol)

C28H51O12P (610.3118)


   

Cyclo(D-trp-D-asp-pro-D-val-leu)

2-{1,4,7,10-tetrahydroxy-9-[(1H-indol-3-yl)methyl]-6-(2-methylpropyl)-13-oxo-3-(propan-2-yl)-3H,6H,9H,12H,13H,15H,16H,17H,17ah-pyrrolo[1,2-a]1,4,7,10,13-pentaazacyclopentadecan-12-yl}acetate

C31H42N6O7 (610.3115)


D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D065128 - Endothelin Receptor Antagonists

   

[2-hydroxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropyl] (9Z,12Z)-nonadeca-9,12-dienoate

[2-hydroxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropyl] (9Z,12Z)-nonadeca-9,12-dienoate

C28H51O12P (610.3118)


   

1-(9Z-octadecenoyl)-2-succinyl-sn-glycero-3-phospho-(1-sn-glycerol)

1-(9Z-octadecenoyl)-2-succinyl-sn-glycero-3-phospho-(1-sn-glycerol)

C28H51O12P (610.3118)


   

PG 14:0/8:2;O2

PG 14:0/8:2;O2

C28H51O12P (610.3118)


   

PG 14:1/8:1;O2

PG 14:1/8:1;O2

C28H51O12P (610.3118)


   

PG 18:1/4:1;O2

PG 18:1/4:1;O2

C28H51O12P (610.3118)


   

LPI 19:2

LPI 19:2

C28H51O12P (610.3118)


   

(2s)-n-[(3s)-1-carbamimidoyl-2-hydroxypiperidin-3-yl]-1-[(2r)-2-{[1,2-dihydroxy-4-(4-hydroxyphenyl)butylidene]amino}-3-(4-hydroxyphenyl)propanoyl]-4-methylpyrrolidine-2-carboximidic acid

(2s)-n-[(3s)-1-carbamimidoyl-2-hydroxypiperidin-3-yl]-1-[(2r)-2-{[1,2-dihydroxy-4-(4-hydroxyphenyl)butylidene]amino}-3-(4-hydroxyphenyl)propanoyl]-4-methylpyrrolidine-2-carboximidic acid

C31H42N6O7 (610.3115)


   

n-(1-carbamimidoyl-2-hydroxypiperidin-3-yl)-1-(2-{[1,2-dihydroxy-4-(4-hydroxyphenyl)butylidene]amino}-3-(4-hydroxyphenyl)propanoyl)-4-methylpyrrolidine-2-carboximidic acid

n-(1-carbamimidoyl-2-hydroxypiperidin-3-yl)-1-(2-{[1,2-dihydroxy-4-(4-hydroxyphenyl)butylidene]amino}-3-(4-hydroxyphenyl)propanoyl)-4-methylpyrrolidine-2-carboximidic acid

C31H42N6O7 (610.3115)


   

(2s)-n-[(3r)-1-carbamimidoyl-2-hydroxypiperidin-3-yl]-1-[(2r)-2-{[1,2-dihydroxy-4-(4-hydroxyphenyl)butylidene]amino}-3-(4-hydroxyphenyl)propanoyl]-4-methylpyrrolidine-2-carboximidic acid

(2s)-n-[(3r)-1-carbamimidoyl-2-hydroxypiperidin-3-yl]-1-[(2r)-2-{[1,2-dihydroxy-4-(4-hydroxyphenyl)butylidene]amino}-3-(4-hydroxyphenyl)propanoyl]-4-methylpyrrolidine-2-carboximidic acid

C31H42N6O7 (610.3115)


   

(2s,4s)-n-(5-carbamimidamido-1-oxopentan-2-yl)-1-[(2r)-2-{[(2r)-1,2-dihydroxy-3-(4-hydroxyphenyl)propylidene]amino}-4-(4-hydroxyphenyl)butanoyl]-4-methylpyrrolidine-2-carboximidic acid

(2s,4s)-n-(5-carbamimidamido-1-oxopentan-2-yl)-1-[(2r)-2-{[(2r)-1,2-dihydroxy-3-(4-hydroxyphenyl)propylidene]amino}-4-(4-hydroxyphenyl)butanoyl]-4-methylpyrrolidine-2-carboximidic acid

C31H42N6O7 (610.3115)


   

n-(5-carbamimidamido-1-oxopentan-2-yl)-1-(2-{[1,2-dihydroxy-3-(4-hydroxyphenyl)propylidene]amino}-4-(4-hydroxyphenyl)butanoyl)-4-methylpyrrolidine-2-carboximidic acid

n-(5-carbamimidamido-1-oxopentan-2-yl)-1-(2-{[1,2-dihydroxy-3-(4-hydroxyphenyl)propylidene]amino}-4-(4-hydroxyphenyl)butanoyl)-4-methylpyrrolidine-2-carboximidic acid

C31H42N6O7 (610.3115)